ANGO
Price
$10.97
Change
+$0.01 (+0.09%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
233.95M
34 days until earnings call
MLSS
Price
$0.90
Change
-$0.01 (-1.10%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
47.46M
75 days until earnings call
Interact to see
Advertisement

ANGO vs MLSS

Header iconANGO vs MLSS Comparison
Open Charts ANGO vs MLSSBanner chart's image
AngioDynamics
Price$10.97
Change+$0.01 (+0.09%)
Volume$6.05K
Capitalization233.95M
Milestone Scientific
Price$0.90
Change-$0.01 (-1.10%)
Volume$2.7K
Capitalization47.46M
ANGO vs MLSS Comparison Chart
Loading...
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANGO vs. MLSS commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a Buy and MLSS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ANGO: $10.97 vs. MLSS: $0.90)
Brand notoriety: ANGO and MLSS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANGO: 113% vs. MLSS: 112%
Market capitalization -- ANGO: $233.95M vs. MLSS: $47.46M
ANGO [@Medical Specialties] is valued at $233.95M. MLSS’s [@Medical Specialties] market capitalization is $47.46M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANGO’s FA Score shows that 0 FA rating(s) are green whileMLSS’s FA Score has 0 green FA rating(s).

  • ANGO’s FA Score: 0 green, 5 red.
  • MLSS’s FA Score: 0 green, 5 red.
According to our system of comparison, ANGO is a better buy in the long-term than MLSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANGO’s TA Score shows that 5 TA indicator(s) are bullish while MLSS’s TA Score has 4 bullish TA indicator(s).

  • ANGO’s TA Score: 5 bullish, 4 bearish.
  • MLSS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ANGO is a better buy in the short-term than MLSS.

Price Growth

ANGO (@Medical Specialties) experienced а +9.70% price change this week, while MLSS (@Medical Specialties) price change was -7.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.32%. For the same industry, the average monthly price growth was +4.56%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

ANGO is expected to report earnings on Jul 09, 2025.

MLSS is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Medical Specialties (+0.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANGO($234M) has a higher market cap than MLSS($47.5M). ANGO YTD gains are higher at: 19.651 vs. MLSS (-5.250). MLSS has higher annual earnings (EBITDA): -6.99M vs. ANGO (-28.49M). ANGO has more cash in the bank: 60.9M vs. MLSS (4.62M). MLSS has less debt than ANGO: MLSS (422K) vs ANGO (4.73M). ANGO has higher revenues than MLSS: ANGO (330M) vs MLSS (9.81M).
ANGOMLSSANGO / MLSS
Capitalization234M47.5M493%
EBITDA-28.49M-6.99M408%
Gain YTD19.651-5.250-374%
P/E Ratio44.84N/A-
Revenue330M9.81M3,365%
Total Cash60.9M4.62M1,318%
Total Debt4.73M422K1,121%
FUNDAMENTALS RATINGS
ANGO vs MLSS: Fundamental Ratings
ANGO
MLSS
OUTLOOK RATING
1..100
2056
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9295
PRICE GROWTH RATING
1..100
3860
P/E GROWTH RATING
1..100
59100
SEASONALITY SCORE
1..100
3850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANGO's Valuation (72) in the Medical Specialties industry is in the same range as MLSS (95). This means that ANGO’s stock grew similarly to MLSS’s over the last 12 months.

ANGO's Profit vs Risk Rating (98) in the Medical Specialties industry is in the same range as MLSS (100). This means that ANGO’s stock grew similarly to MLSS’s over the last 12 months.

ANGO's SMR Rating (92) in the Medical Specialties industry is in the same range as MLSS (95). This means that ANGO’s stock grew similarly to MLSS’s over the last 12 months.

ANGO's Price Growth Rating (38) in the Medical Specialties industry is in the same range as MLSS (60). This means that ANGO’s stock grew similarly to MLSS’s over the last 12 months.

ANGO's P/E Growth Rating (59) in the Medical Specialties industry is somewhat better than the same rating for MLSS (100). This means that ANGO’s stock grew somewhat faster than MLSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANGOMLSS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 22 days ago
72%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYRIX55.87N/A
N/A
Rydex Retailing Inv
IIRSX11.63N/A
N/A
Voya Russell Small Cap Index Port I
HHHRX17.97N/A
N/A
Hartford Schroders Emerging Mkts Eq R3
FIQJX22.35N/A
N/A
Fidelity Advisor Intl Sm Cap Opps Z
VYMVX17.59N/A
N/A
Voya Mid Cap Research Enhanced Index R

ANGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
+0.09%
STRRP - ANGO
48%
Loosely correlated
+3.41%
MXCT - ANGO
37%
Loosely correlated
+4.82%
NVST - ANGO
35%
Loosely correlated
+0.11%
ICUI - ANGO
35%
Loosely correlated
+0.63%
RGEN - ANGO
35%
Loosely correlated
+1.73%
More

MLSS and

Correlation & Price change

A.I.dvisor tells us that MLSS and BLFS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and BLFS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
-1.13%
BLFS - MLSS
27%
Poorly correlated
+3.04%
ESTA - MLSS
26%
Poorly correlated
+1.31%
SRDX - MLSS
26%
Poorly correlated
+1.66%
GKOS - MLSS
25%
Poorly correlated
-3.74%
VTAK - MLSS
25%
Poorly correlated
+2.55%
More